Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia (Q81523534)
Jump to navigation
Jump to search
scientific article published on 30 October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia |
scientific article published on 30 October 2007 |
Statements
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia (English)
Chris Saddler
Peter Ouillette
Lisa Kujawski
Sanjeev Shangary
Moshe Talpaz
Mark Kaminski
Harry Erba
Kerby Shedden
30 October 2007